Pharmacoeconomics and Health Outcomes Research Iberia (Spain)
In research, Pharmacoeconomics and Health Outcomes Research Iberia (Spain) stands highest in Medicine (#9,591 of 17,978 worldwide) and Health Sciences (#12,047 of 20,462 worldwide), over all time.
- World rank, all time
- #30,689 of 42,892
- Rank in Spain
- #712 of 927
- Research works
- 469 ▼ 62% vs 2013–17
- Citations
- 3.7k 7.9 per fractional work
- Top-10% rate
- 15.3% record average 16.5%
- Open access
- 35% world 28%
What is Pharmacoeconomics and Health Outcomes Research Iberia (Spain) known for in research?
The fields where it stands highest, over all time, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works |
|---|---|---|---|---|
| MedicineField | #9,591 of 17,978 | 7.4% | 268 | |
| Health SciencesDomain | #12,047 of 20,462 | 7.2% | 302 |
Each strip is that field’s whole ranked pool, with the notch where Pharmacoeconomics and Health Outcomes Research Iberia (Spain) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 4.0×. Every wedge is a field page.
Who are the top researchers at Pharmacoeconomics and Health Outcomes Research Iberia (Spain)?
Ranked on the composite score, Miguel Á. Casado, Lolkje Theodora Wilhelmina de Jong-van den Berg and Itziar Oyagüez lead among researchers whose main affiliation is Pharmacoeconomics and Health Outcomes Research Iberia (Spain).
- 1 Miguel Á. Casado Spain · #405,398 worldwide 46 citations · 32 works
- 2 Lolkje Theodora Wilhelmina de Jong-van den Berg Spain · #1,002,142 worldwide 1 citations · 20 works
- 3 Itziar Oyagüez Spain · #1,307,349 worldwide 28 citations · 27 works
- 4 Rogier Klok Spain · #1,627,034 worldwide 0 citations · 17 works
Which keywords describe research at Pharmacoeconomics and Health Outcomes Research Iberia (Spain)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Epidemiology, Treatment, Immune Response, Antiviral Therapy, Liver Disease, Hepatitis C Virus, Ribavirin and Hepatocellular Carcinoma.
- Pathogenesis
- Factor VIII
- Management
- Prophylaxis
- Diagnosis
- Antiretroviral Therapy
- Immunotherapy
- Quality of Life
- Ribavirin
- Hepatitis C Virus
- Antiviral Therapy
- Treatment
- Epidemiology
- Immune Response
- Liver Disease
- Hepatocellular Carcinoma
- Inflammation
- Global Burden
- Cardiovascular Disease
- Chronic Hepatitis B
- Hepatitis B Virus
- Efficacy
- Public Health
- Hemophilia
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 24 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 24 words, with their numbers
- Epidemiology6▲ 5.5×36 topics
- Treatment3▲ 9.7×11 topics
- Immune Response3▲ 20×4 topics
- Antiviral Therapy3▲ 112×3 topics
- Liver Disease3▲ 116×2 topics
- Hepatitis C Virus2▲ 196×1 topic
- Hepatocellular Carcinoma2▲ 31×3 topics
- Ribavirin2▲ 196×1 topic
- Inflammation2▲ 2.8×10 topics
- Quality of Life2▲ 3.6×14 topics
- Global Burden1▲ 8.9×5 topics
- Immunotherapy1▲ 6.7×9 topics
- Cardiovascular Disease1▲ 3.9×8 topics
- Antiretroviral Therapy1▲ 25×5 topics
- Chronic Hepatitis B1▲ 119×1 topic
- Diagnosis1▲ 4.5×7 topics
- Hepatitis B Virus1▲ 119×1 topic
- Prophylaxis1▲ 33×2 topics
- Efficacy1▲ 51×2 topics
- Management1▲ 4.8×6 topics
- Public Health1▲ 2.5×6 topics
- Factor VIII1▲ 244×1 topic
- Hemophilia1▲ 244×1 topic
- Pathogenesis1▲ 6.9×7 topics
Which research topics does Pharmacoeconomics and Health Outcomes Research Iberia (Spain) publish most on?
By volume in 2022–2025: Hepatitis C virus research, Hepatitis B Virus Studies, Hemophilia Treatment and Research and Hepatitis Viruses Studies and Epidemiology.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Hepatitis C virus research Hepatology 2 works
- 2 Hepatitis B Virus Studies Epidemiology 1 works
- 3 Hemophilia Treatment and Research Hematology 1 works
- 4 Hepatitis Viruses Studies and Epidemiology Hepatology 1 works
- 5 Economic and Financial Impacts of Cancer Economics and Econometrics 1 works
- 6 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 1 works
- 7 CAR-T cell therapy research Oncology 0 works
- 8 Asthma and respiratory diseases Physiology 0 works
- 9 Hepatocellular Carcinoma Treatment and Prognosis Hepatology 0 works
- 10 Liver Diseases and Immunity Hepatology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Pharmacoeconomics and Health Outcomes Research Iberia (Spain)'s research output changed?
Output in 2018–2022 was 62% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Pozuelo de Alarcón
- Universidad Complutense de Madrid
- Universidad Autónoma de Madrid
- Universidad Politécnica de Madrid
- Consejo Superior de Investigaciones Científicas
- Universidad Carlos III de Madrid
- Universidad Rey Juan Carlos
- Universidad Nacional de Educación a Distancia
- Hospital Universitario La Paz
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.